MX394245B - Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. - Google Patents
Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia.Info
- Publication number
- MX394245B MX394245B MX2018014080A MX2018014080A MX394245B MX 394245 B MX394245 B MX 394245B MX 2018014080 A MX2018014080 A MX 2018014080A MX 2018014080 A MX2018014080 A MX 2018014080A MX 394245 B MX394245 B MX 394245B
- Authority
- MX
- Mexico
- Prior art keywords
- fibromyalgia
- syndrome associated
- carbamate compound
- prevent
- treat
- Prior art date
Links
- 208000001640 Fibromyalgia Diseases 0.000 title abstract 6
- 208000011580 syndromic disease Diseases 0.000 title abstract 3
- -1 CARBAMATE COMPOUND Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160061392 | 2016-05-19 | ||
| PCT/KR2017/005173 WO2017200318A1 (ko) | 2016-05-19 | 2017-05-18 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018014080A MX2018014080A (es) | 2019-04-04 |
| MX394245B true MX394245B (es) | 2025-03-19 |
Family
ID=60325216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018014080A MX394245B (es) | 2016-05-19 | 2017-05-18 | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10849882B2 (enExample) |
| EP (1) | EP3459543B1 (enExample) |
| JP (1) | JP7071287B2 (enExample) |
| KR (1) | KR102489052B1 (enExample) |
| CN (1) | CN109475529B (enExample) |
| AU (1) | AU2017265839B2 (enExample) |
| BR (1) | BR112018073553A2 (enExample) |
| DK (1) | DK3459543T3 (enExample) |
| ES (1) | ES2935596T3 (enExample) |
| MX (1) | MX394245B (enExample) |
| PL (1) | PL3459543T3 (enExample) |
| RU (1) | RU2753525C2 (enExample) |
| WO (1) | WO2017200318A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102635941B1 (ko) * | 2016-12-14 | 2024-02-13 | 에스케이바이오팜 주식회사 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
| EP3711757B1 (en) * | 2017-11-14 | 2025-05-07 | SK Biopharmaceuticals Co., Ltd. | Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease |
| ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
| CN111432812A (zh) | 2017-11-14 | 2020-07-17 | 爱思开生物制药株式会社 | 用于预防、减轻或治疗失神发作或显示失神发作的癫痫的氨基甲酸酯化合物的用途 |
| KR20210062029A (ko) | 2018-10-19 | 2021-05-28 | 에스케이바이오팜 주식회사 | 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도 |
| AU2020389425B2 (en) * | 2019-11-22 | 2026-03-05 | Sk Biopharmaceuticals Co., Ltd. | Oral pharmaceutical composition comprising carbamate compound and preparation method therefor |
| IT202300007314A1 (it) | 2023-04-14 | 2024-10-14 | Soal Pharma Srl | Integratore alimentare per il trattamento della fibromialgia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3415840A (en) * | 1965-10-22 | 1968-12-10 | American Home Prod | Pyrazole-1-ethanol derivatives |
| RU2299729C2 (ru) * | 2001-07-16 | 2007-05-27 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| US8404461B2 (en) | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| EP2496227B1 (en) * | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
-
2017
- 2017-05-16 KR KR1020170060714A patent/KR102489052B1/ko active Active
- 2017-05-18 PL PL17799675.8T patent/PL3459543T3/pl unknown
- 2017-05-18 EP EP17799675.8A patent/EP3459543B1/en active Active
- 2017-05-18 DK DK17799675.8T patent/DK3459543T3/da active
- 2017-05-18 WO PCT/KR2017/005173 patent/WO2017200318A1/ko not_active Ceased
- 2017-05-18 US US16/302,858 patent/US10849882B2/en active Active
- 2017-05-18 CN CN201780030906.XA patent/CN109475529B/zh active Active
- 2017-05-18 AU AU2017265839A patent/AU2017265839B2/en active Active
- 2017-05-18 MX MX2018014080A patent/MX394245B/es unknown
- 2017-05-18 ES ES17799675T patent/ES2935596T3/es active Active
- 2017-05-18 RU RU2018144785A patent/RU2753525C2/ru active
- 2017-05-18 BR BR112018073553-1A patent/BR112018073553A2/pt not_active Application Discontinuation
- 2017-05-18 JP JP2018560460A patent/JP7071287B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2935596T3 (es) | 2023-03-08 |
| PL3459543T3 (pl) | 2023-04-11 |
| EP3459543B1 (en) | 2022-12-21 |
| US20190298694A1 (en) | 2019-10-03 |
| BR112018073553A2 (pt) | 2019-03-19 |
| CN109475529A (zh) | 2019-03-15 |
| RU2018144785A (ru) | 2020-06-19 |
| EP3459543A4 (en) | 2020-01-15 |
| KR102489052B1 (ko) | 2023-01-16 |
| DK3459543T3 (da) | 2023-02-13 |
| CA3024286A1 (en) | 2017-11-23 |
| WO2017200318A1 (ko) | 2017-11-23 |
| MX2018014080A (es) | 2019-04-04 |
| US10849882B2 (en) | 2020-12-01 |
| JP7071287B2 (ja) | 2022-05-18 |
| RU2753525C2 (ru) | 2021-08-17 |
| CN109475529B (zh) | 2022-02-22 |
| RU2018144785A3 (enExample) | 2020-08-11 |
| AU2017265839B2 (en) | 2022-10-27 |
| AU2017265839A1 (en) | 2018-12-13 |
| KR20170131242A (ko) | 2017-11-29 |
| EP3459543A1 (en) | 2019-03-27 |
| JP2019516707A (ja) | 2019-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202202097B (en) | Amino pyrimidine ssao inhibitors | |
| CY1124652T1 (el) | Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες | |
| SA518400356B1 (ar) | مثبطات الأرجيناز واستخداماتها العلاجية | |
| MX2021006011A (es) | Un inhibidor de la quinasa aurora a para su uso en el tratamiento del neuroblastoma. | |
| MY199409A (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| BR112018070602A2 (pt) | composto, composição farmacêutica, uso do composto, e, método para tratar uma doença ou distúrbio | |
| BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
| MX384905B (es) | Degradadores de proteínas de bromodominio y dominioextraterminal (bet). | |
| MX395482B (es) | Compuestos antiproliferativos y metodos de uso de los mismos | |
| MX2018014080A (es) | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. | |
| EA201891203A1 (ru) | Гетероциклические соединения в качестве иммуномодуляторов | |
| UA118149C2 (uk) | Інгібітор jak | |
| EA201792116A1 (ru) | Ингибитор янус-киназы | |
| EA201990044A1 (ru) | Гетероциклические соединения в качестве антибактериальных средств | |
| MX2019009501A (es) | Compuestos de amino piridina utiles como inhibidores de ssao. | |
| MX2020003593A (es) | Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos. | |
| PH12019501690A1 (en) | Pyrimidine compound and pharmaceutical use thereof | |
| HK1254954A1 (zh) | Lpt-723和免疫检查点抑制剂组合物及其治疗方法 | |
| MX388175B (es) | Compuestos terapéuticos y métodos para utilizarlos | |
| JOP20190053A1 (ar) | مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط | |
| MX2021012096A (es) | Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo. | |
| EA035519B9 (ru) | 1,3,4-тиадиазольные соединения и их применение в лечении рака | |
| DOP2018000134A (es) | Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
| EA201792265A1 (ru) | Способы лечения сердечно-сосудистых заболеваний |